Interview guide
| 1. What are the major areas of agreement and disagreement with regard to tobacco harm reduction? What are your personal perspectives on these major issues? |
| 2. How will the debate regarding tobacco harm reduction evolve over the next five years? |
| 3. What is the potential of tobacco harm reduction to reduce health risks to smokers in the future, and why? |
| 4. What kinds of unintended consequences, if any, do you think there might be from the use of harm reduction products? |
| 5. What do you perceive to be the characteristics of “good” and “bad” or “dangerous” harm reduction products? Are there any current products on the market that meet these definitions? |
| 6. What, if anything, should the US government do in terms of regulating harm reduction products, and why? |
| 7. Where will the US be in regard to regulating harm reduction products 5–10 years from now? |
| 8. With regard to tobacco harm reduction, what are the importance and prospects for eventual collaboration between: (a) the public health community and the tobacco industry, (b) the public health community and the pharmaceutical industry, and (c) the tobacco and pharmaceutical industries? |
| 9. What do you think about the Institute of Medicine’s conclusion regarding the use of surrogate measures to indirectly measure harm? What are areas of greatest scientific uncertainty? |
| 10. Is there anything else about the topic of tobacco harm reduction that we haven’t talked about that you would like to discuss? |